Effect of melatonin on phase I and II biotransformation enzymes in streptozotocin-induced diabetic rats

A. C. Maritim, B. H. Moore, R. A. Sanders, J. B. Watkins

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Melatonin, a pineal secretory product known to be a scavenger of oxygen radicals, is widely used as a dietary supplement, although its toxicity has not been well characterized. Melatonin was administered (10 mg/kg IP in gum tragacanth, once a day for 4 successive days) to normal and 30-day streptozotocin-induced diabetic male Sprague-Dawley rats, after which activities of phase I and phase II biotransformation enzymes were assessed in the liver, kidney, intestine, and spleen. Most melatonin-induced effects were seen in the liver, and a few in extrahepatic tissues. In the liver, the effects of diabetes were reversed in two instances: hydroxylation of benzo[a]pyrene and glutathione S-transferase activity toward 1-chloro-2,4-dinitrobenzene. In contrast to its effect on the phase I enzymes studied, whose activities were inhibited or unaffected by melatonin treatment, this treatment led to increased activity of glucuronyl transferase toward 4-methylumbelliferone in intestine of diabetic rats and toward 4-hydroxybiphenyl in liver of normal rats. Hepatic glutathione S-transferase activity was also induced in normal rats after melatonin treatment, though the diabetic induction of this enzyme activity was reversed by melatonin. These results suggest that in addition to being a radical scavenger, melatonin, after 4 days of administration, does not induce the phase I enzymes studied, but may induce some hepatic phase II enzymes in normal but not diabetic rats.

Original languageEnglish
Pages (from-to)277-283
Number of pages7
JournalInternational Journal of Toxicology
Volume19
Issue number4
StatePublished - 2000

Fingerprint

Melatonin
Streptozocin
Biotransformation
Rats
Liver
Enzymes
Glutathione Transferase
Intestines
Tragacanth
Dietary supplements
Hymecromone
Dinitrochlorobenzene
Hydroxylation
Enzyme Induction
Benzo(a)pyrene
Enzyme activity
Medical problems
Transferases
Dietary Supplements
Sprague Dawley Rats

Keywords

  • Antioxidant
  • Biotransformation
  • Diabetes Mellitus
  • Intestine
  • Kidney
  • Liver
  • Melatonin
  • Rat
  • Spleen

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Effect of melatonin on phase I and II biotransformation enzymes in streptozotocin-induced diabetic rats. / Maritim, A. C.; Moore, B. H.; Sanders, R. A.; Watkins, J. B.

In: International Journal of Toxicology, Vol. 19, No. 4, 2000, p. 277-283.

Research output: Contribution to journalArticle

Maritim, A. C. ; Moore, B. H. ; Sanders, R. A. ; Watkins, J. B. / Effect of melatonin on phase I and II biotransformation enzymes in streptozotocin-induced diabetic rats. In: International Journal of Toxicology. 2000 ; Vol. 19, No. 4. pp. 277-283.
@article{d470d71ac22a4787af586a0e82650a01,
title = "Effect of melatonin on phase I and II biotransformation enzymes in streptozotocin-induced diabetic rats",
abstract = "Melatonin, a pineal secretory product known to be a scavenger of oxygen radicals, is widely used as a dietary supplement, although its toxicity has not been well characterized. Melatonin was administered (10 mg/kg IP in gum tragacanth, once a day for 4 successive days) to normal and 30-day streptozotocin-induced diabetic male Sprague-Dawley rats, after which activities of phase I and phase II biotransformation enzymes were assessed in the liver, kidney, intestine, and spleen. Most melatonin-induced effects were seen in the liver, and a few in extrahepatic tissues. In the liver, the effects of diabetes were reversed in two instances: hydroxylation of benzo[a]pyrene and glutathione S-transferase activity toward 1-chloro-2,4-dinitrobenzene. In contrast to its effect on the phase I enzymes studied, whose activities were inhibited or unaffected by melatonin treatment, this treatment led to increased activity of glucuronyl transferase toward 4-methylumbelliferone in intestine of diabetic rats and toward 4-hydroxybiphenyl in liver of normal rats. Hepatic glutathione S-transferase activity was also induced in normal rats after melatonin treatment, though the diabetic induction of this enzyme activity was reversed by melatonin. These results suggest that in addition to being a radical scavenger, melatonin, after 4 days of administration, does not induce the phase I enzymes studied, but may induce some hepatic phase II enzymes in normal but not diabetic rats.",
keywords = "Antioxidant, Biotransformation, Diabetes Mellitus, Intestine, Kidney, Liver, Melatonin, Rat, Spleen",
author = "Maritim, {A. C.} and Moore, {B. H.} and Sanders, {R. A.} and Watkins, {J. B.}",
year = "2000",
language = "English",
volume = "19",
pages = "277--283",
journal = "International Journal of Toxicology",
issn = "1091-5818",
publisher = "SAGE Publications Inc.",
number = "4",

}

TY - JOUR

T1 - Effect of melatonin on phase I and II biotransformation enzymes in streptozotocin-induced diabetic rats

AU - Maritim, A. C.

AU - Moore, B. H.

AU - Sanders, R. A.

AU - Watkins, J. B.

PY - 2000

Y1 - 2000

N2 - Melatonin, a pineal secretory product known to be a scavenger of oxygen radicals, is widely used as a dietary supplement, although its toxicity has not been well characterized. Melatonin was administered (10 mg/kg IP in gum tragacanth, once a day for 4 successive days) to normal and 30-day streptozotocin-induced diabetic male Sprague-Dawley rats, after which activities of phase I and phase II biotransformation enzymes were assessed in the liver, kidney, intestine, and spleen. Most melatonin-induced effects were seen in the liver, and a few in extrahepatic tissues. In the liver, the effects of diabetes were reversed in two instances: hydroxylation of benzo[a]pyrene and glutathione S-transferase activity toward 1-chloro-2,4-dinitrobenzene. In contrast to its effect on the phase I enzymes studied, whose activities were inhibited or unaffected by melatonin treatment, this treatment led to increased activity of glucuronyl transferase toward 4-methylumbelliferone in intestine of diabetic rats and toward 4-hydroxybiphenyl in liver of normal rats. Hepatic glutathione S-transferase activity was also induced in normal rats after melatonin treatment, though the diabetic induction of this enzyme activity was reversed by melatonin. These results suggest that in addition to being a radical scavenger, melatonin, after 4 days of administration, does not induce the phase I enzymes studied, but may induce some hepatic phase II enzymes in normal but not diabetic rats.

AB - Melatonin, a pineal secretory product known to be a scavenger of oxygen radicals, is widely used as a dietary supplement, although its toxicity has not been well characterized. Melatonin was administered (10 mg/kg IP in gum tragacanth, once a day for 4 successive days) to normal and 30-day streptozotocin-induced diabetic male Sprague-Dawley rats, after which activities of phase I and phase II biotransformation enzymes were assessed in the liver, kidney, intestine, and spleen. Most melatonin-induced effects were seen in the liver, and a few in extrahepatic tissues. In the liver, the effects of diabetes were reversed in two instances: hydroxylation of benzo[a]pyrene and glutathione S-transferase activity toward 1-chloro-2,4-dinitrobenzene. In contrast to its effect on the phase I enzymes studied, whose activities were inhibited or unaffected by melatonin treatment, this treatment led to increased activity of glucuronyl transferase toward 4-methylumbelliferone in intestine of diabetic rats and toward 4-hydroxybiphenyl in liver of normal rats. Hepatic glutathione S-transferase activity was also induced in normal rats after melatonin treatment, though the diabetic induction of this enzyme activity was reversed by melatonin. These results suggest that in addition to being a radical scavenger, melatonin, after 4 days of administration, does not induce the phase I enzymes studied, but may induce some hepatic phase II enzymes in normal but not diabetic rats.

KW - Antioxidant

KW - Biotransformation

KW - Diabetes Mellitus

KW - Intestine

KW - Kidney

KW - Liver

KW - Melatonin

KW - Rat

KW - Spleen

UR - http://www.scopus.com/inward/record.url?scp=0033816894&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033816894&partnerID=8YFLogxK

M3 - Article

VL - 19

SP - 277

EP - 283

JO - International Journal of Toxicology

JF - International Journal of Toxicology

SN - 1091-5818

IS - 4

ER -